Lung ultrasound is associated with distinct clinical phenotypes in COVID-19 ARDS: A retrospective observational study

Roy Rafael Dayan,Maayan Blau,Jonathan Taylor,Ariel Hasidim,Ori Galante,Yaniv Almog,Tomer Gat,Darya Shavialiova,Jacob David Miller,Georgi Khazanov,Fahmi Abu Ghalion,Iftach Sagy,Itamar Ben Shitrit,Lior Fuchs
DOI: https://doi.org/10.1371/journal.pone.0304508
IF: 3.7
2024-06-04
PLoS ONE
Abstract:ARDS is a heterogeneous syndrome with distinct clinical phenotypes. Here we investigate whether the presence or absence of large pulmonary ultrasonographic consolidations can categorize COVID-19 ARDS patients requiring mechanical ventilation into distinct clinical phenotypes. This is a retrospective study performed in a tertiary-level intensive care unit in Israel between April and September 2020. Data collected included lung ultrasound (LUS) findings, respiratory parameters, and treatment interventions. The primary outcome was a composite of three ARDS interventions: prone positioning, high PEEP, or a high dose of inhaled nitric oxide. A total of 128 LUS scans were conducted among 23 patients. The mean age was 65 and about two-thirds were males. 81 scans identified large consolidation and were classified as "C-type", and 47 scans showed multiple B-lines with no or small consolidation and were classified as "B-type". The presence of a "C-type" study had 2.5 times increased chance of receiving the composite primary outcome of advanced ARDS interventions despite similar SOFA scores, Pao2/FiO2 ratio, and markers of disease severity (OR = 2.49, %95CI 1.40–4.44). The presence of a "C-type" profile with LUS consolidation potentially represents a distinct COVID-19 ARDS subphenotype that is more likely to require aggressive ARDS interventions. Further studies are required to validate this phenotype in a larger cohort and determine causality, diagnostic, and treatment responses.
multidisciplinary sciences
What problem does this paper attempt to address?